Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel L Baker

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Circulation|July 30, 2003
Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaquesEnno Rother, Richard Brandl, Daniel L Baker, et al.
Bioorganic & Medicinal Chemistry|April 7, 2009
Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogsE Jeffrey North, Daniel A Osborne, Peter K Bridson, et al.
Journal of Molecular Graphics & Modelling|November 4, 2018
GPCR homology model template selection benchmarking: Global versus local similarity measuresPaige N Castleman, Chandler K Sears, Judith A Cole, et al.
Journal of Molecular Graphics & Modelling|October 5, 2011
Ligand-based autotaxin pharmacophore models reflect structure-based docking resultsCatrina D Mize, Ashley M Abbott, Samantha B Gacasan, et al.
Biochemistry|January 22, 2008
Determination of protein-RNA interaction sites in the Cbf5-H/ACA guide RNA complex by mass spectrometric protein footprintingDaniel L Baker, Nicholas T Seyfried, Hong Li, et al.
Bioorganic & Medicinal Chemistry|November 27, 2007
Virtual screening approaches for the identification of non-lipid autotaxin inhibitorsAbby L Parrill, Uniqua Echols, Tran Nguyen, et al.
Bioorganic & Medicinal Chemistry|July 3, 2013
Autotaxin inhibition: development and application of computational tools to identify site-selective lead compoundsDerek D Norman, Ayolah Ibezim, Whitney E Scott, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Stereochemical properties of lysophosphatidic acid receptor activation and metabolismKazuaki Yokoyama, Daniel L Baker, Tamas Virag, et al.
Frontiers in Microbiology|June 28, 2021
2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial BiofilmsZoe L Harrison, Rukhsana Awais, Michael Harris, et al.
Cellular Signalling|December 23, 2003
Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate levelJunming Yue, Kazuaki Yokoyama, Louisa Balazs, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Circulation|July 30, 2003
Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaquesEnno Rother, Richard Brandl, Daniel L Baker, et al.
Bioorganic & Medicinal Chemistry|April 7, 2009
Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogsE Jeffrey North, Daniel A Osborne, Peter K Bridson, et al.
Journal of Molecular Graphics & Modelling|November 4, 2018
GPCR homology model template selection benchmarking: Global versus local similarity measuresPaige N Castleman, Chandler K Sears, Judith A Cole, et al.
Journal of Molecular Graphics & Modelling|October 5, 2011
Ligand-based autotaxin pharmacophore models reflect structure-based docking resultsCatrina D Mize, Ashley M Abbott, Samantha B Gacasan, et al.
Biochemistry|January 22, 2008
Determination of protein-RNA interaction sites in the Cbf5-H/ACA guide RNA complex by mass spectrometric protein footprintingDaniel L Baker, Nicholas T Seyfried, Hong Li, et al.
Bioorganic & Medicinal Chemistry|November 27, 2007
Virtual screening approaches for the identification of non-lipid autotaxin inhibitorsAbby L Parrill, Uniqua Echols, Tran Nguyen, et al.
Bioorganic & Medicinal Chemistry|July 3, 2013
Autotaxin inhibition: development and application of computational tools to identify site-selective lead compoundsDerek D Norman, Ayolah Ibezim, Whitney E Scott, et al.
Biochimica Et Biophysica Acta|June 19, 2002
Stereochemical properties of lysophosphatidic acid receptor activation and metabolismKazuaki Yokoyama, Daniel L Baker, Tamas Virag, et al.
Frontiers in Microbiology|June 28, 2021
2-Heptylcyclopropane-1-Carboxylic Acid Disperses and Inhibits Bacterial BiofilmsZoe L Harrison, Rukhsana Awais, Michael Harris, et al.
Cellular Signalling|December 23, 2003
Mice with transgenic overexpression of lipid phosphate phosphatase-1 display multiple organotypic deficits without alteration in circulating lysophosphatidate levelJunming Yue, Kazuaki Yokoyama, Louisa Balazs, et al.
Pageof 7